- Home
- YPF vs PCVX Comparison
YPF vs PCVX Comparison
Compare YPF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YPF
- PCVX
- Stock Information
- Founded
- YPF 1977
- PCVX 2013
- Country
- YPF Argentina
- PCVX United States
- Employees
- YPF N/A
- PCVX N/A
- Industry
- YPF Integrated oil Companies
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- YPF Energy
- PCVX Health Care
- Exchange
- YPF Nasdaq
- PCVX Nasdaq
- Market Cap
- YPF 15.9B
- PCVX 13.2B
- IPO Year
- YPF 1993
- PCVX 2020
- Fundamental
- Price
- YPF $45.00
- PCVX $78.14
- Analyst Decision
- YPF Buy
- PCVX Strong Buy
- Analyst Count
- YPF 8
- PCVX 9
- Target Price
- YPF $37.64
- PCVX $149.38
- AVG Volume (30 Days)
- YPF 2.3M
- PCVX 1.1M
- Earning Date
- YPF 03-05-2025
- PCVX 02-25-2025
- Dividend Yield
- YPF N/A
- PCVX N/A
- EPS Growth
- YPF 426.45
- PCVX N/A
- EPS
- YPF 2.00
- PCVX N/A
- Revenue
- YPF $15,678,121,770.00
- PCVX N/A
- Revenue This Year
- YPF N/A
- PCVX N/A
- Revenue Next Year
- YPF N/A
- PCVX N/A
- P/E Ratio
- YPF $25.82
- PCVX N/A
- Revenue Growth
- YPF 269.29
- PCVX N/A
- 52 Week Low
- YPF $14.53
- PCVX $58.10
- 52 Week High
- YPF $47.43
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- YPF 62.86
- PCVX 32.14
- Support Level
- YPF $44.20
- PCVX $80.10
- Resistance Level
- YPF $47.43
- PCVX $81.70
- Average True Range (ATR)
- YPF 1.56
- PCVX 3.12
- MACD
- YPF -0.20
- PCVX -0.13
- Stochastic Oscillator
- YPF 60.55
- PCVX 5.68
About YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. The company's upstream operations consist of the exploration, development, and production of crude oil, natural gas, and LPG. Its downstream operations include the refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG, and bio-fuels. The company generates maximum revenue from the downstream segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.